ClinicaliQ Trial Snapshot
- A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis — Active Not Recruiting • Phase III • Rheumatology • NCT06095115.
- A trial testing whether JNJ-77242113 effectively treats moderate to severe plaque psoriasis in teenagers and adults.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The purpose of this study is see how effective is JNJ-77242113 in participants with moderate to severe plaque psoriasis. Conditions: Plaque Psoriasis Interventions: JNJ-77242113, Placebo Lead Sponsor: Janssen Research & Development, LLC Planned Enrollment: 684 participants